Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
Clinical trial NCT00005859 · COMPLETED
Trial details
- NCT number
- NCT00005859
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-05-16
- Primary completion
- 2005-07-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.